We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Rail Vision Ltd. (NASDAQ:RVSN) saw its shares rise on Friday after announcing a major achievement in railway safety. The ...

Kimberly-Clark Corporation is a favorite for income investors despite recent challenges in growth and international markets.

Despite the real problems with the additional indication being sought for suzetrigine, this drop in the stock is still an ...

Kairos Pharma's ENV-105 aims to overcome resistance in CRPC and EGFR-mutant NSCLC, with key data releases expected in 2025.

Both stocks have had strong runs in 2024. Let's consider which semiconductor looks like the better buy heading into 2025.

Subscribers to Chart of the Week received this commentary on Sunday, December 22.

Jim Cramer, the host of Mad Money, expressed strong views regarding day trading on Friday, urging novice investors to avoid ...

Conditions are favorable for these seven small-cap ETFs that have strong growth momentum entering 2025.

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...